Bruinsma et al. BMC Public Health 2011, 11(Suppl 5):S7 http://www.biomedcentral.com/1471-2458/11/S5/S7 29. Greenblatt RB, McDonough PG, Mahesh VB: Estrogen therapy in inhibition of growth. J Clin Endocrinol Metab 1966, 26:1185-1191. 30. Whitelaw MJ: Experiences in treating excessive height in girls with cyclic oestradiol valerate. A ten year survey. Acta Endocrinol (Copenh) 1967, 54:473-484. 31. Andersen H, Jacobsen BB, Kastrup KW, Krabbe S, Peitersen B, Petersen KE, Thamdrup E, Wichmann R: Treatment of girls with excessive height prediction. Follow-up of forty girls treated with intramuscular estradiol and progesterone. Acta Paediatr Scand 1980, 69:293-297. 32. Kuhn N, Blunck W, Stahnke N, Wiebel J, Willig RP: Estrogen treatment in tall girls. Acta Paediatr Scand 1977, 66:161-167. 33. Binder G, Grauer ML, Wehner AV, Wehner F, Ranke MB: Outcome in tall stature. Final height and psychological aspects in 220 patients with and without treatment. Eur J Pediatr 1997, 156:905-910. 34. de Waal WJ, Janssen A, van Bussbach J, de Muinck Keizer-Schrama S, Aarsen R, Slijper F, Drop S: Chapter 8: Psychosocial aspects in constitutionally tall stature. Unpublished PhD Thesis Rotterdam: Division of Endocrinology, Erasmus University; 1996. 35. Lecointre C, Toublanc JE: Psychological indications for treatment of tall stature in adolescent girls. J Pediatr Endocrinol Metab 1997, 10:529-531. 36. Barnard ND, Scialli AR, Bobela S: The current use of estrogens for growth- suppressant therapy in adolescent girls. J Pediatr Adolesc Gynecol 2002, 15:23-26. 37. Moon RJ, Davies JH: Evaluation of tall stature. J Paediatr Child Health 2010, 20:43-45. 38. Gunther DF, Diekema DS: Attenuating growth in children with profound developmental disability: a new approach to an old dilemma. Arch Pediatr Adolesc Med 2006, 160:1013-1017. 39. Hughes G, Ryle G: Hormone tests on teenage girls referred to inquiry. The Age 1997. 40. Jennings G: Tall girls. Afternoon with Gael Jennings Melbourne: ABC Radio, 3LO; 1997. 41. Giusti RM, Iwamoto K, Hatch EE: Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995, 122:778-788. 42. Herbst AL, Ulfelder H, Poskanzer DC: Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971, 284:878-881. 43. Venn A: Using medical records in epidemiological research. Archives and Manuscripts 2003, 31(2):51-59. 44. Nash S, Tilley BC, Kurland LT, Gundersen J, Barnes AB, Labarthe D, Donohew PS, Kovacs L: Identifying and tracing a population at risk: the DESAD Project experience. Am J Public Health 1983, 73:253-259. 45. Bryant J, Baxter L, Cave CB, Milne R: Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev 2007, CD004440. 46. Mills JL, Fradkin J, Schonberger L, Gunn W, Thomson RA, Piper J, Wysowski D, Brown P: Status report on the US human growth hormone recipient follow-up study. Horm Res 1990, 33:116-120. 47. Allars M: Report / Inquiry into the Use of Pituitary Derived Hormones in Australia and Creutzfeldt-Jakob Disease. Canberra: Australian Govt. Pub. Service; 1994. 48. Bruinsma F, Skene L, Venn A: Accessing patients’s records without individual consent to epidemiological research. J Law Med 2000, 8:76-80. doi:10.1186/1471-2458-11-S5-S7 Cite this article as: Bruinsma et al.: Looking back in time: conducting a cohort study of the long-term effects of treatment of adolescent tall girls with synthetic hormones. BMC Public Health 2011 11(Suppl 5):S7. Page 8 of 8 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit